Immunomodulation of T(H)2 biased immunity with mucosal administration of nanoemulsion adjuvant

T(H)2-biased immune responses are associated with inadequate protection against some pathogens and with cancer, colitis, asthma and allergy. Since most currently used vaccine adjuvants induce a T(H)2-biased response, this has led to interest in developing adjuvants capable of activating T(H)1 immuni...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Vaccine
Main Authors: Bielinska, Anna U., O’Konek, Jessica J., Janczak, Katarzyna W., Baker, James R.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Science 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4962973/
https://ncbi.nlm.nih.gov/pubmed/27317451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.06.043
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki